Patents by Inventor William P. Schiemann

William P. Schiemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genes and proteins associated with angiogenesis and uses thereof
    Patent number: 9505819
    Abstract: Disclosed is a panel of biomarkers associated with angiogenesis, and the use of such biomarkers (genes, proteins, homologues and analogs thereof) to regulate angiogenesis. Methods for identifying compounds useful for regulating angiogenesis and conditions related thereto are disclosed.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: November 29, 2016
    Assignee: National Jewish Health
    Inventors: William P. Schiemann, Allan R. Albig
  • GENES AND PROTEINS ASSOCIATED WITH ANGIOGENESIS AND USES THEREOF
    Publication number: 20150087589
    Abstract: Disclosed is a panel of biomarkers associated with angiogenesis, and the use of such biomarkers (genes, proteins, homologues and analogs thereof) to regulate angiogenesis. Methods for identifying compounds useful for regulating angiogenesis and conditions related thereto are disclosed.
    Type: Application
    Filed: December 6, 2013
    Publication date: March 26, 2015
    Applicant: National Jewish Health
    Inventors: William P. Schiemann, Allan R. Albig
  • Genes and proteins associated with angiogenesis and uses thereof
    Patent number: 8629107
    Abstract: Disclosed is a panel of biomarkers associated with angiogenesis, and the use of such biomarkers (genes, proteins, homologues and analogs thereof) to regulate angiogenesis. Methods for identifying compounds useful for regulating angiogenesis and conditions related thereto are disclosed.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: January 14, 2014
    Assignee: National Jewish Health
    Inventors: William P. Schiemann, Allan R. Albig
  • GENES AND PROTEINS ASSOCIATED WITH ANGIOGENESIS AND USES THEREOF
    Publication number: 20120283188
    Abstract: Disclosed is a panel of biomarkers associated with angiogenesis, and the use of such biomarkers (genes, proteins, homologues and analogs thereof) to regulate angiogenesis. Methods for identifying compounds useful for regulating angiogenesis and conditions related thereto are disclosed.
    Type: Application
    Filed: March 9, 2012
    Publication date: November 8, 2012
    Applicant: NATIONAL JEWISH HEALTH
    Inventors: William P. Schiemann, Allan R. Albig
  • CYSTATIN C AS AN ANTAGONIST OF TGF-BETA AND METHODS RELATED THERETO
    Publication number: 20120214233
    Abstract: Disclosed are Cystatin C (CysC) homologues, including CystC homologues that act as antagonists or inhibitors of transforming growth factor-? (TGF-?). Also disclosed are methods to identify CystC homologues that are antagonists or inhibitors of TGF-? and compositions and therapeutic methods using CystC and homologues thereof to regulate the activity of TGF-?, and TGF-?-mediated tumor malignancy and invasion and other TGF-?-mediated fibrotic or proliferative conditions and diseases.
    Type: Application
    Filed: September 29, 2011
    Publication date: August 23, 2012
    Applicant: NATIONAL JEWISH HEALTH
    Inventor: William P. Schiemann
  • Genes and proteins associated with angiogenesis and uses thereof
    Patent number: 8158107
    Abstract: Disclosed is a panel of biomarkers associated with angiogenesis, and the use of such biomarkers (genes, proteins, homologues and analogs thereof) to regulate angiogenesis. Methods for identifying compounds useful for regulating angiogenesis and conditions related thereto are disclosed.
    Type: Grant
    Filed: October 2, 2006
    Date of Patent: April 17, 2012
    Assignee: National Jewish Health
    Inventors: William P. Schiemann, Allan R. Albig
  • Cystatin C as an antagonist of TGF-? and methods related thereto
    Patent number: 8058396
    Abstract: Disclosed are Cystatin C (CysC) homologues, including CystC homologues that act as antagonists or inhibitors of transforming growth factor-? (TGF-?). Also disclosed are methods to identify CystC homologues that are antagonists or inhibitors of TGF-? and compositions and therapeutic methods using CystC and homologues thereof to regulate the activity of TGF-?, and TGF-?-mediated tumor malignancy and invasion and other TGF-?-mediated fibrotic or proliferative conditions and diseases.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: November 15, 2011
    Assignee: National Jewish Health
    Inventor: William P. Schiemann
  • Cystatin C as an Antagonist of TGF-BETA and Methods Related Thereto
    Publication number: 20100267644
    Abstract: Disclosed are Cystatin C (CysC) homologues, including CystC homologues that act as antagonists or inhibitors of transforming growth factor-? (TGF-?). Also disclosed are methods to identify CystC homologues that are antagonists or inhibitors of TGF-? and compositions and therapeutic methods using CystC and homologues thereof to regulate the activity of TGF-?, and TGF-?-mediated tumor malignancy and invasion and other TGF-?-mediated fibrotic or proliferative conditions and diseases.
    Type: Application
    Filed: May 18, 2010
    Publication date: October 21, 2010
    Applicant: NATIONAL JEWISH HEALTH
    Inventor: WILLIAM P. SCHIEMANN
  • Cystatin C as an antagonist of TGF-? and methods related thereto
    Patent number: 7749958
    Abstract: Disclosed are Cystatin C (CysC) homologues, including CystC homologues that act as antagonists or inhibitors of transforming growth factor-? (TGF-?). Also disclosed are methods to identify CystC homologues that are antagonists or inhibitors of TGF-? and compositions and therapeutic methods using CystC and homologues thereof to regulate the activity of TGF-?, and TGF-?-mediated tumor malignancy and invasion and other TGF-?-mediated fibrotic or proliferative conditions and diseases.
    Type: Grant
    Filed: September 10, 2007
    Date of Patent: July 6, 2010
    Assignee: National Jewish Health
    Inventor: William P. Schiemann
  • CYSTATIN C AS AN ANTAGONIST OF TGF-BETA AND METHODS RELATED THERETO
    Publication number: 20090093401
    Abstract: Disclosed are Cystatin C (CysC) homologues, including CystC homologues that act as antagonists or inhibitors of transforming growth factor-? (TGF-?). Also disclosed are methods to identify CystC homologues that are antagonists or inhibitors of TGF-? and compositions and therapeutic methods using CystC and homologues thereof to regulate the activity of TGF-?, and TGF-?-mediated tumor malignancy and invasion and other TGF-?-mediated fibrotic or proliferative conditions and diseases.
    Type: Application
    Filed: September 10, 2007
    Publication date: April 9, 2009
    Applicant: NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
    Inventor: William P. Schiemann
  • Cystatin C as an antagonist of TGF-? and methods related thereto
    Patent number: 7282477
    Abstract: Disclosed are Cystatin C (CysC) homologues, including CystC homologues that act as antagonists or inhibitors of transforming growth factor-? (TGF-?). Also disclosed are methods to identify CystC homologues that are antagonists or inhibitors of TGF-? and compositions and therapeutic methods using CystC and homologues thereof to regulate the activity of TGF-?, and TGF-?-mediated tumor malignancy and invasion and other TGF-?-mediated fibrotic or proliferative conditions and diseases.
    Type: Grant
    Filed: October 15, 2004
    Date of Patent: October 16, 2007
    Assignee: National Jewish Medical and Research Center
    Inventor: William P. Schiemann
  • Fibulin-5 and uses thereof
    Publication number: 20040126788
    Abstract: Disclosed are methods for the use of Fibulin-5 as a marker for cancer diagnostics and other cancer screening assays, including to monitor the treatment of a patient with cancer, and for the use of Fibulin-5 as a cancer therapeutic and/or anti-angiogenesis therapeutic. Also disclosed are methods for identifying regulators of TGF&bgr; activity and methods for identifying regulators of tumorigenicity and angiogenesis.
    Type: Application
    Filed: August 13, 2003
    Publication date: July 1, 2004
    Inventors: William P. Schiemann, Harvey F. Lodish